                         SEQUENCE LISTING

<110>  KSQ Therapeutics, Inc.
 
<120>  GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED 
       IMMUNOTHERAPY

<130>  4195.008PC02/EKS/CLD/EJH

<150>  US 62/800,121
<151>  2019-02-01

<150>  US 62/916,988
<151>  2019-10-18

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  OR1A1 gRNA

<400>  1
gctgaccagt aactcccagg                                                   20


<210>  2
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  PRDM1 gRNA

<400>  2
ttggacagat ctattccaga                                                   20


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  TNFRSF4 gRNA

<400>  3
ggatgtgcgt gggggctcgg                                                   20


